JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$4.76B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.21B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$3.81B |
| 4 |
Apple
AAPL
|
+$3.39B |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$3.1B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.48B |
| 2 |
S&P Global
SPGI
|
+$2.45B |
| 3 |
Coca-Cola
KO
|
+$1.73B |
| 4 |
Adobe
ADBE
|
+$1.59B |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.3B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.97% |
| 2 | Technology | 21.69% |
| 3 | Healthcare | 9.58% |
| 4 | Consumer Discretionary | 9.07% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4626
WisdomTree Voya Yield Enhanced USD Universal Bond Fund
UNIY
$1.26B
| $475K | ﹤0.01% |
9,733
+8,901
| +1,070% | +$434K |
2023 Q4
1 quarter
|
|
|
DDL
4627
Dingdong
DDL
$455M
| $474K | ﹤0.01% |
388,835
+113,232
| +41% | +$146K |
2022 Q2
7 quarters
|
|
4628
CALL
Comstock Resources
CRK
$4.01B
| $474K | ﹤0.01% |
+51,100
| New | +$420K |
2024 Q1
0 quarters
|
|
4629
First Bancorp
FNLC
$381M
| $474K | ﹤0.01% |
19,244
+7,416
| +63% | +$182K |
2017 Q4
25 quarters
|
|
4630
Organogenesis Holdings
ORGO
$172M
| $473K | ﹤0.01% |
166,625
+120,161
| +259% | +$408K |
2019 Q1
20 quarters
|
|
|
CONX
4631
DELISTED
CONX Corp. Class A Common Stock
CONX
| $472K | ﹤0.01% |
44,589
| – | – |
2020 Q4
13 quarters
|
|
4632
Mission Produce
AVO
$1.12B
| $472K | ﹤0.01% |
39,758
-20,699
| -34% | -$221K |
2020 Q4
13 quarters
|
|
|
INZY
4633
DELISTED
Inozyme Pharma
INZY
| $472K | ﹤0.01% |
61,577
+27,241
| +79% | +$149K |
2020 Q3
14 quarters
|
|
4634
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.2B
| $471K | ﹤0.01% |
16,280
-5,875
| -27% | -$162K |
2021 Q3
10 quarters
|
|
4635
Designer Brands
DBI
$304M
| $471K | ﹤0.01% |
43,054
-174,901
| -80% | -$1.68M |
2015 Q1
36 quarters
|
|
|
CVGW
4636
DELISTED
Calavo Growers
CVGW
| $470K | ﹤0.01% |
16,891
+1,799
| +12% | +$50.5K |
2013 Q2
43 quarters
|
|
4637
Xometry
XMTR
$6.34B
| $468K | ﹤0.01% |
27,702
-27,920
| -50% | -$757K |
2021 Q2
11 quarters
|
|
4638
Arteris
AIP
$1.19B
| $468K | ﹤0.01% |
63,916
+43,031
| +206% | +$277K |
2021 Q4
9 quarters
|
|
4639
ALX Oncology
ALXO
$153M
| $467K | ﹤0.01% |
41,897
-5,686
| -12% | -$79.9K |
2020 Q3
14 quarters
|
|
|
EQIN
4640
Columbia U.S. Equity Income ETF
EQIN
$306M
| $467K | ﹤0.01% |
10,482
| – | – |
2022 Q4
5 quarters
|
|
4641
Tredegar Corp
TG
$245M
| $466K | ﹤0.01% |
71,487
+8,157
| +13% | +$39.7K |
2013 Q2
43 quarters
|
|
4642
Red Violet
RDVT
$1.25B
| $466K | ﹤0.01% |
23,819
+15,228
| +177% | +$279K |
2021 Q4
9 quarters
|
|
4643
Southern First Bancshares
SFST
$572M
| $465K | ﹤0.01% |
14,641
+6,727
| +85% | +$231K |
2017 Q4
25 quarters
|
|
4644
Civista Bancshares
CIVB
$555M
| $465K | ﹤0.01% |
30,218
+13,017
| +76% | +$209K |
2016 Q4
29 quarters
|
|
4645
Franklin US Core Dividend Tilt Index ETF
UDIV
$162M
| $464K | ﹤0.01% |
11,494
+3,384
| +42% | +$130K |
2023 Q2
3 quarters
|
|
|
GETY
4646
DELISTED
GETTY IMAGES HLDGS INC A
GETY
| $464K | ﹤0.01% |
+111,774
| New | +$518K |
2024 Q1
0 quarters
|
|
4647
WisdomTree US Quality Growth Fund
QGRW
$3.3B
| $464K | ﹤0.01% |
+11,286
| New | +$441K |
2024 Q1
0 quarters
|
|
4648
Gogoro
GGR
$64M
| $463K | ﹤0.01% |
12,594
+3,692
| +41% | +$142K |
2022 Q3
6 quarters
|
|
|
PLYA
4649
DELISTED
Playa Hotels & Resorts
PLYA
| $463K | ﹤0.01% |
+47,739
| New | +$422K |
2024 Q1
0 quarters
|
|
4650
Werewolf Therapeutics
HOWL
$44.7M
| $461K | ﹤0.01% |
71,184
+71,101
| +85,664% | +$414K |
2021 Q2
11 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2024 Portfolio in Review
As of Q1 2024, JP Morgan Chase held 8,132 positions worth $1.18T, up 14% from $1.04T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
JP Morgan Chase deployed $48.7B of net new capital in Q1 2024, opening 625 new positions and adding to 3,255 existing holdings. Its largest new stake was Flutter Entertainment: 1,314,201 shares worth $260M.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vanguard Total International Bond ETF, an estimated $2.48B trimmed.
- JP Morgan Chase's largest Q1 2024 buy was Flutter Entertainment: 1,314,201 shares worth $260M.
- JP Morgan Chase added most to Vanguard S&P 500 ETF in Q1 2024, an estimated $4.76B increase.
- JP Morgan Chase's biggest Q1 2024 reduction was Vanguard Total International Bond ETF, cutting an estimated $2.48B.
- JP Morgan Chase fully exited BlackRock Flexible Income ETF in Q1 2024, selling an estimated $139M.
- JP Morgan Chase's ten largest holdings make up 21% of its $1.18T portfolio in Q1 2024.
- JP Morgan Chase opened 625 new positions and closed 764 in Q1 2024.
- JP Morgan Chase's portfolio value rose 14% quarter-over-quarter to $1.18T.
Based on JP Morgan Chase's 13F filing for Q1 2024, filed 10 May 2024.